|
CPSF4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.99950000000704E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.407860E-02 |
| Normal-vs-Stage2 |
2.133400E-01 |
| Normal-vs-Stage3 |
6.905800E-02 |
| Normal-vs-Stage4 |
1.807200E-01 |
| Stage1-vs-Stage2 |
6.754600E-01 |
| Stage1-vs-Stage3 |
4.193400E-01 |
| Stage1-vs-Stage4 |
2.399400E-01 |
| Stage2-vs-Stage3 |
8.431600E-01 |
| Stage2-vs-Stage4 |
5.719200E-01 |
| Stage3-vs-Stage4 |
6.363600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.408900E-04 |
| Normal-vs-AfricanAmerican |
9.900200E-03 |
| Normal-vs-Asian |
2.107000E-01 |
| Caucasian-vs-AfricanAmerican |
4.036000E-01 |
| Caucasian-vs-Asian |
2.626600E-01 |
| AfricanAmerican-vs-Asian |
5.137000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.380760E-04 |
| Normal-vs-Female |
8.276900E-03 |
| Male-vs-Female |
9.361400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.394230E-01 |
| Normal-vs-Extreme_Weight |
6.756400E-03 |
| Normal-vs-Obese |
5.537600E-03 |
| Normal-vs-Extreme_Obese |
5.868800E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.721000E-01 |
| Normal_Weight-vs-Obese |
4.204000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.860000E-01 |
| Extreme_Weight-vs-Obese |
7.544800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.415000E-01 |
| Obese-vs-Extreme_Obese |
5.399600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.015600E-03 |
| Normal-vs-Age(41-60Yrs) |
1.394530E-04 |
| Normal-vs-Age(61-80Yrs) |
1.848390E-02 |
| Normal-vs-Age(81-100Yrs) |
5.394800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.037030E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.310300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.920200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.946550E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.864400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.381000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.29510000004929E-07 |
| Normal-VS-Type2 PRCC |
7.750600E-01 |
| Normal-VS-KIRP CIMP |
6.380300E-02 |
| Normal-VS-Unclassified PRCC |
1.955810E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.821800E-04 |
| Type1 PRCC-VS-KIRP CIMP |
5.024000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.379820E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.245700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.025000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.597370E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.417000E-01 |
| Normal-vs-N1 |
5.555600E-02 |
| Normal-vs-N2 |
5.924400E-01 |
| N0-vs-N1 |
1.462350E-01 |
| N0-vs-N2 |
6.687400E-01 |
| N1-vs-N2 |
8.031400E-01 |
|
|
